Kintor pharmaceuticals
Web6 jul. 2024 · Pyrilutamide is a non-steroidal anti-androgen (NSAA). NSAAs work by blocking testosterone and DHT from binding with the androgen receptor in the follicle. This is different from GT20029, another compound developed by Suzhou Kintor Pharmaceuticals for the treatment of hair loss and acne. GT20029 (AR-PROTAC) works by degrading androgen … Web15 jul. 2024 · Kintor and Fosun Pharma will jointly work on the emergency use authorisation (EUA) applications, promotion and sales of the drug for Covid-19 treatment. …
Kintor pharmaceuticals
Did you know?
Web5 dec. 2024 · KX-826 is an androgen receptor (AR) antagonist and a potential first-in-class topical drug for the treatment of AGA and acne vulgaris. For the AGA indication, in September 2024, Kintor Pharma announced the primary endpoint of the phase II clinical trial of KX-826 on male adults was met, with results demonstrating a positive efficacy and …
Web6 apr. 2024 · BEIJING, April 6 (Reuters) - China's Kintor Pharmaceutical (9939.HK) said on Wednesday its potential COVID-19 treatment proxalutamide effectively reduced the risk of hospitalization and death in a ... Web9 Suzhou Kintor Pharmaceuticals, Inc., Suzhou, Jiangsu, China. Electronic address: [email protected]. 10 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Web11 okt. 2024 · Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet ... Web14 mei 2024 · May 14 (Reuters) - Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had "completed the first patient enrollment and dosing" in a late-stage U.S. clinical trial of its experimental COVID-19 treatment.
Web9 sep. 2024 · The compounds and compositions can be used for treatment of androgen receptor-associated diseases or disorders, such as prostate cancer, benign prostatic hypertrophy, male hair loss and hypertrichosis. Type: Grant. Filed: March 8, 2012. Date of Patent: December 22, 2015. Assignee: SUZHOU KINTOR PHARMACEUTICALS, INC.
Web31 dec. 2024 · Kintor Pharma - Developing Novel Drugs and Commercialisation Platform Confidential Disclaimer By attending the meeting where this presentation is made, or by reading the presentation materials, you agree to be bound by the following limitations: skyline booster club sammamishWeb14 jul. 2024 · Dr. Tong Youzhi, the Founder, Chairman and CEO of Kintor Pharma, said:” Coronavirus is continuing its spread across the world with more than 12 million confirmed cases in 188 countries. sweatcoin canadaWeb31 dec. 2024 · Kintor Pharmaceutical : Pharma Announces 2024 Annual Results and Recent Business Progress. PU. 03/30. Kintor Pharmaceutical Limited Reports … skyline booth rentalWebKintor Pharmaceutical Limited develops and markets drugs. The Company produces and sells androgen receptor antagonists, small molecule innovative drugs, and other products. skyline booking agencyWeb3 jan. 2024 · Hasini Devarasetti. Kintor Pharmaceutical has dosed the first participant in the Phase III clinical trial of KX-826 (pyrilutamide) to treat male androgenic alopecia (AGA) patients in China. An androgen receptor (AR) antagonist, KX-826 is claimed to be a first-in-class topical drug developed to treat AGA and acne vulgaris. skyline black screenWebKintor is conducting a separate phase 2 trial in America. If things go well, it'll be available in America in 2024 or 2025. Edit: Folliclethought has a nice pipeline on upcoming drugs here • I don't know about 2024 in China tho, phase 3 will be done in Q4. So as I've read it could be expected in mid to late 2024 on Chinese Market. sweatcoin cadastrarWeb31 dec. 2024 · Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business ... skyline bothell